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Abstract
The development of a fluorescent assay to detect activity of the mitochondrial cAMP-dependent
protein kinase (PKA) is described. A peptide-based sensor was utilized to quantify the relative
amount of PKA activity present in each compartment of the mitochondria (the outer membrane,
the intermembrane space, and the matrix). In the process of validating this assay, we discovered
that PKA activity is regulated by the protease calpain. Upon exposure of bovine heart
mitochondria to digitonin, Ca2+, and a variety of electron transport chain inhibitors, the regulatory
subunits of the PKA holoenzyme (R2C2) are digested, releasing active catalytic subunits. This
proteolysis is attenuated by calpain inhibitor I (ALLN).
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1. Introduction
Members of the protein kinase family have been implicated in numerous cell functions,
ranging from ATP generation to cell growth and division.[1] Kinases catalyze the transfer of
a phosphoryl group from ATP to the hydroxyl groups of serine, threonine, or tyrosine
residues in proteins. The cAMP-dependent protein kinase (PKA) is a serine/threonine kinase
that exists as an inactive tetrameric holoenzyme consisting of two regulatory subunits and
two catalytic subunits. The conventional mode of activation of PKA involves the binding of
cAMP to the regulatory subunits, causing release of the catalytic subunits, which then
phosphorylate a myriad of proteins.[2, 3] PKA is anchored to a variety of intracellular
locations via interaction with A-kinase anchoring proteins (AKAPs).
PKA activity at the mitochondria is associated with the regulation of apoptosis,
mitochondrial respiration, and ATP synthesis.[4-6] PKA phosphorylates the proapoptotic
protein BAD, which prevents cell death.[5] PKA also phosphorylates apoptotic protease-
activating factor (Apaf-1), which inhibits the formation of the apoptosome and activation of
caspase-9.[7] In addition, PKA increases mitochondrial respiration via phosphorylation of
subunits contained within complexes I and IV.[4] Although it is well known that PKA is
present at the mitochondria, the relative amount of enzyme present in each compartment
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(outer membrane, intermembrane space, matrix) remains unclear. Orr and colleagues
demonstrated that type II PKA is located on the outer membrane of mitochondria in male
germ cells.[8] However, PKA has also been shown to be associated with the inner
membrane/matrix.[9, 10] Most of these studies employed electron microscopy to pinpoint
the suborganelle location of the holoenzyme. However, since the catalytic subunit can
diffuse through membranes [11], holoenzyme location as assessed by electron microscopy
may not represent the location of the active enzyme. Given this information we sought to
develop an assay that would quantify the relative amounts of PKA activity present in each
major compartment of the mitochondria.
2. Development of a Fluorescent Sensor for Mitochondrial PKA Activity
Fluorescent sensors of protein kinase activity furnish a direct means to assess catalytic
action in a continuous fashion.[12] However, in many instances, the fluorescent response is
modest, thereby necessitating the use of large amounts of sensor to ensure a measureable
signal. Consequently, we sought to develop a sensor with a large dynamic range, thereby
reducing the quantity of sensor required for signal detection and thus the perturbation on the
biological system under scrutiny. We employed three coumarin derivatives as the kinase-
responsive fluorophores [13]. These fluorophores were appended to the N-terminus of
peptides of the general structure coumarin-Aoc-GRTGRRFSYP-amide (1-3, Figure 1, Aoc =
aminooctanoic acid). We anticipated that negatively charged fluorescent quenchers would
interact with the positively charged peptide, resulting in the loss of coumarin fluorescence.
However, upon phosphorylation the peptide interacts with a phosphoserine-binding 14-3-3
domain, displacing the quencher, and resulting in a burst of fluorescence (Scheme 1).
Peptides 1 - 3 were screened with a variety of negatively charged dyes. Acid green 27 (4,
Figure 1) furnishes a deep fluorescent quench as well as a dramatic PKA-induced
fluorescence increase, with peptide 1 displaying a remarkable 152-fold fluorescence
enhancement (Table 1).
We employed the strategy depicted in Figure 2 to assess the location of PKA activity in
bovine heart mitochondria. Perhaps the most straightforward way to achieve this would be
to subfractionate the mitochondria (i.e. separate the outer membrane, the intermembrane
space, and the matrix) and assess the activity of each compartment. However, digitonin is
typically used to remove the outer membrane and release the contents of the intermembrane
space. Digitonin has been demonstrated to cause leakage of matrix proteins in bovine heart
mitochondria,[14] thereby contaminating the intermembrane space fraction, and resulting in
an inaccurate assessment of relative amount of protein. Therefore, intact bovine heart
mitochondria were treated with cAMP, and PKA activity assessed utilizing the assay
described above with peptide 1. Since the outer membrane of mitochondria is permeant to
small molecules less than 5000 Da, including peptide 1, this measures the PKA activity at
both the outer membrane and intermembrane space. Proteolysis of the outer membrane
proteins with trypsin prior to assessing PKA activity distinguishes outer membrane activity
from intermembrane space activity. Sonication of whole mitochondria followed by treatment
with cAMP affords the total PKA activity (outer membrane, intermembrane space, matrix).
With information in hand, the relative percentage of PKA activity can be calculated for each
major compartment: 85% in the matrix, 6% in the intermembrane space, and 9% on the
outer membrane.[14]
3. Proteolytic Regulation of Mitochondrial PKA
While attempting to subfractionate bovine heart mitochondria with digitonin we observed
leakage of matrix proteins and proteolysis of both isoforms of the regulatory subunits (RI
and RII).[15] By contrast, the catalytic subunit (C) remained intact. Since multiple isoforms
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of calpain, a Ca2+-activated protease, have recently been reported to reside in the
mitochondria,[16, 17] we investigated whether this protease played a role in the digestion of
the PKA R subunits. Indeed, attenuation of digitonin-induced R subunit proteolysis was
observed upon the addition of calpain inhibitor I (N-acetyl-Leu-Leu-Nle-al, ALLN) (Figure
3a). Furthermore, addition of Ca2+ enhances this proteolysis, consistent with involvement of
a Ca2+-dependent protease (Figure 3b). We observed direct activation of mitochondrial
calpain by digitonin and Ca2+ using a fluorescent methyl-coumarin substrate (Figure 3c).
To further confirm this calpain-mediated selective proteolysis, isolated R and C subunits
were subjected to calpain I digestion.[15] Both are prone to digestion; however, the amount
of CaCl2 drastically affects selectivity. The R subunit is selectively digested with 10 μM
CaCl2; whereas the C subunit also suffers partial proteolysis at Ca2+ concentrations ≥ 100
μM (Figure 4a). This suggests that, under physiological Ca2+ concentrations (<100 μM), the
R subunit can be selectively digested, thereby releasing free C subunit. The holoenzyme
R2C2 was also subjected to digestion by calpain I. Interestingly, proteolysis of the R subunit,
but not the C subunit, even occurs at 100 μM CaCl2, implying that the C subunit is more
resistant to proteolysis while in holoenzyme form (Figure 4b). One possible explanation is
the formation of an R subunit fragment that protects the C subunit from calpain-mediated
proteolysis.
We also investigated whether this selective R subunit proteolysis releases active C subunit
from the mitochondria into the supernatant. Mitochondria were treated with either cAMP (2
mM) or Ca2+ (100 μM) in the presence of soluble adenylate cyclase inhibitor KH7 (25 μM),
centrifuged, and the supernatant examined for release of active C subunit. Western blot
analysis of the supernatant shows that C subunit is released into the supernatant upon
exposure to either Ca2+ or cAMP. Furthermore, the calpain inhibitor ALLN attenuates Ca2+-
induced release of C subunit into the supernatant, consistent with a calpain-dependent
process (Figure 5). Finally, we confirmed that the released C subunit is catalytically active.
Since Ca2+ is a known inducer of the mitochondrial pore transition (MPT)[18], we decided
to investigate whether other reagents that induce MPT also activate PKA in a calpain-
dependent fashion. Both electron transport chain inhibitors and uncouplers have been linked
to induction of MPT[19-22]. Mitochondria were exposed to rotenone (complex I inhibitor),
antimycin A (complex III inhibitor), sodium azide (complex IV inhibitor), oligomycin (F1F0
ATPase inhibitor) as well as the uncoupler CCCP in the presence and absence of ALLN,
centrifuged, and the supernatant examined for released C subunit by Western blot. Exposure
to rotenone, azide and CCCP elicit the largest enhancements in PKA activity, all of which
are attenuated by ALLN (Figure 6). Antimycin A and oligomycin also induced PKA
activity, but to a lesser extent. In addition, the activity elicited by oligomycin proved to be
calpain independent (Figure 6).
4. Conclusion
A PKA sensor with a large dynamic range (a phosphorylation-induced 152-fold
enhancement in fluorescence) has been used to assess the suborganelle distribution of
mitochondrial PKA activity. We found that PKA activity predominantly resides in the
matrix (85%), although detectable amounts are present on the outer membrane (9%) and in
the intermembrane space (6%).[14] We note that a variety of genetically-encoded protein
kinase sensors have been described, most commonly by a mechanism in which
phosphorylation induces conformational change and a subsequent florescent readout via a
pair of FRET-based green fluorescent proteins.[23] Although a detailed comparison of the
relative attributes of peptide-based and genetically-encoded sensors is beyond scope of this
brief review, we do note that peptide-based systems can readily be prepared with extremely
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bright fluorophores that emit between the long UV and the near IR. Furthermore, the large
dynamic range enjoyed by the sensor described in this study exemplifies the possibilities
inherent in a system that is essentially non-fluorescent in its unphosphorylated state.
During the validation of this assay, we discovered that PKA activity is regulated in a
calpain-dependent fashion.[15] Furthermore, metabolic inhibitors elicit enhanced PKA
activity in bovine heart mitochondria by this mechanism. Azide (complex IV inhibitor) and
rotenone (complex I inhibitor) are the most robust calpain-mediated activators of PKA
identified in this study. Interestingly, treatment of neurons and cadiomyocytes with azide
and rotenone is known to result in the activation of calpain. [24, 25] Consequently, it is
tempting to speculate that stress-induced MPT and Ca2+ release [26] promotes the activation
of calpain, the subsequent selective degradation of the R subunits of the PKA holoenzyme,
and release of active C subunit. The induction of PKA activity by mitochondrial stress could
be a protective mechanism since PKA action is known to inhibit apoptosis [27] and promote
enhanced respiration rates [28,29].
Abbreviations
ALLN, calpain inhibitor I N-acetyl-Leu-Leu-Nle-CHO; C subunit, catalytic subunit; CCCP,
chlorophenylhydrazone
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• Development of a fluorescent sensor for PKA with a large dynamic range
• Determination of the suborganelle location of mitochondrial PKA activity
• Discovery of a proteolytic regulation of mitochondrial PKA activity
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Structures of the coumarin derivatives 1 – 3 of the general form fluorophore-Aoc-
GRTGRRFSYP-amide. The fluorescent quencher Acid Green 27 (4) was identified from a
library of forty-seven dyes. Reprinted with permission from [14]. Copyright 2010 American
Chemical Society.
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Protein kinase-catalyzed phosphorylation of a fluorescently quenched peptide generates a
fluorescent response in the presence of the phosphoSer-binding 14-3-3 domain. Reprinted
with permission from [14]. Copyright 2010 American Chemical Society.
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Strategy for assessing PKA activity on the outer membrane (blue), in the intermembrane
space (red) and in the matrix (yellow). PKA activity of intact mitochondria (A) is due to
enzyme present on the outer membrane and in the intermembrane space. Trypsinized (i)
mitochondria (B) lack outer membrane proteins and thus only intermembrane space PKA is
present. Sonicated (ii) mitochondria (C) furnishes enzyme from all three compartments and
thus represents total mitochondrial PKA. Reprinted with permission from [14]. Copyright
2010 American Chemical Society.
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Digitonin and Ca2+-induced digestion of mitochondrial PKA. A. Bovine heart mitochondria
incubated with digitonin in the presence or absence of ALLN where black bar = untreated
mitochondria, dark gray bar = digitonin-exposed mitochondria, and the light gray bar =
digitonin and ALLN (calpain inhibitor I)-exposed mitochondria. B. Bovine heart
mitochondria incubated with digitonin and CaCl2 in the presence or absence of ALLN where
black bar = untreated mitochondria, dark gray bar = digitonin/CaCl2-exposed mitochondria,
and the light gray bar = digitonin/CaCl2 and ALLN (calpain inhibitor I)-exposed
mitochondria. C. Calpain activity (assessed utilizing the fluorescent substrate N-succinyl-
Leu-Tyr-7-amido-4-methylcoumarin) from bovine heart mitochondria incubated with
digitonin (black trace), digitonin and CaCl2 (gray trace), or buffer alone (inset). Reprinted
with permission from [15]. Copyright 2012 American Chemical Society.
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Calpain digestion of C, R, and R2C2. A. Calpain 1 was added to C or R (I and II) subunit in
the presence or absence of ALLN. The reaction was initiated by the addition of variable
concentrations of CaCl2, and incubated at 37 °C for 20 min: R subunit (◆), C subunit (▲),
R subunit and ALLN (•), and C subunit and ALLN (X). B. Calpain 1 was added to the R2C2
holoenzyme in the presence of 100 μM CaCl2 for 0.5, 1.5, and 2.0 h and the C (○) and R (•)
subunits subsequently quantified via western blot analysis (inset). Adapted with permission
from [15]. Copyright 2012 American Chemical Society.
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Ca2+-induced PKA activation: release of active C subunit. A. Mitochondria were treated
with cAMP or CaCl2, centrifuged, and the pellet and supernatant processed for western blot
analysis. B. Mitochondria were incubated with the soluble adenylate cyclase inhibitor KH7
for 30 min, then treated with CaCl2 in the presence or absence of ALLN, centrifuged, and
the supernatant analyzed for C subunit by western blot. Quantification of untreated (black
bar), Ca2+-exposed (dark gray bar), and Ca2+/ALLN-exposed (light gray bar) mitochondria.
Adapted with permission from [15]. Copyright 2012 American Chemical Society.
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Metabolic inhibitors induce activation of PKA in a calpain-dependent fashion. Mitochondria
were exposed to oligomycin (5 μM), antimycin A (5 μM), rotenone (10 μM), CCCP (5
μM), or sodium azide (2 mM) in the presence or absence of ALLN (500 μM) for 30 min at
37 °C and subsequently centrifuged. The supernatants were analyzed by western blot for the
presence of the C subunit. The relative amount of C subunit released from untreated (black
bar), metabolic inhibitor-exposed (gray bar), and metabolic inhibitor/ALLN-exposed
mitochondria. Reprinted with permission from [15]. Copyright 2012 American Chemical
Society.
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Table 1
Photophysical properties, fluorescent fold increase, Km, and Vmax for the PKA-catalyzed phosphorylation of
sensors 1 – 3 (where sensor = Fluorophore-Aoc-GRTGRRFSYP-amide). Kinetic properties were acquired in
the presence of quencher 4 and the 14-3-3 domain. Reprinted with permission from [14]. Copyright 2010
American Chemical Society.
Sensor (λex/λem) Fluorescent Fold-Increase Km (μM) Vmax (μmol/min·mg)
1 (420/475 nm) 152 2.2 ± 0.1 0.53 ± 0.03
2 (437/477 nm) 150 1.9 ± 0.1 0.34 ± 0.04
3 (450/490 nm) 28 6.2 ± 0.1 0.20 ± 0.09
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